Home Biosimilar Antibodies Others Others Samrotamab (Anti-LRRC15 / LIB)
For research use only. Not for use in humans.

Samrotamab (Anti-LRRC15 / LIB)

Synonyms: null

Samrotamab (Anti-LRRC15 / LIB) is a fully human monoclonal antibody against LRRC15. MW: 145.5 kD.

Samrotamab (Anti-LRRC15 / LIB)

1 Citation

The Nobel Prize

17 Nobel Prize winners have used Selleck products

Shimon Sakaguchi

Nature Communications 2025,16, Article number:1325

David Baker

Dev Cell 2023, 58(20):2163-2180.e9.

David Julius

Cell 2017, 185-198.e16

Michael Houghton

Cell Chem Biol, 2020, 27(7):780-792.e5

Charles M. Rice

Cell 2018, 172(3):423-438.e25

Quality Control

Batch: Purity: 99% Protein concentration: 5.3mg/ml Endotoxin Level: ＜1EU/mg
99

Mechanism of Action

Description
Samrotamab (Anti-LRRC15 / LIB) is a fully human monoclonal antibody against LRRC15. MW: 145.5 kD.

Product Details

CAS No. 2052591-32-7
Molecular Weight 145.5 kDa
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100 mM Pro-Ac, 20mM Arg, pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.